Finance

Lists
Why is ANGO up 2,88%?
Dive Deeper
ANGO:NASDAQ
AngioDynamics, Inc.
11,21 $
+2,88%
(+0,31) 1D
14 қаз., 15:32:31 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ANGO...
Open
10,79 $
High
11,48 $
Low
10,73 $
Mkt. cap
471,57 млн
Avg. vol.
744,34 м.
Volume
1,12 млн
52-wk high
16,29 $
52-wk low
9,39 $
EPS
-0,88 $
Beta
0,30
Shares outstanding
42,05 млн
No. of employees
632
Open
10,79 $
High
11,48 $
Low
10,73 $
Mkt. cap
471,57 млн
Avg. vol.
744,34 м.
Volume
1,12 млн
52-wk high
16,29 $
52-wk low
9,39 $
EPS
-0,88 $
Beta
0,30
Shares outstanding
42,05 млн
No. of employees
632
News stories
From web sources and news partners
About AngioDynamics, Inc.
CEOJames Clemmer
Employees632
Founded1988 ж. 09 ақп.
Headquarters-
SectorMedical device
Websiteangiodynamics.com
Analyst ratings
Based on 2 analysts giving stock ratings to ANGO in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for ANGO in the last 3 months.
Highest
Current 11,21 $
20,00 $ (+78,36%)
Average
19,00 $ (+69,44%)
Lowest
18,00 $ (+60,52%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yi Chen
H.C. Wainwright
Buy
Reiterated
18,00 $
+60,5%
10/14/2026
John Young CFA
Canaccord Genuity
Buy
Reiterated
20,00 $
+78,4%
10/09/2026
Frank Takkinen
Lake Street
Buy
Maintained
24,00 $
+114%
07/14/2026
Ilya Zubkov
Freedom Capital Markets
Buy
Initiated
16,00 $
+42,7%
04/06/2026
Last report
2026 ж. 08 қаз.
Fiscal period
Q1 2027
-0,04 $ / -0,11 $
+64,70%beat
Revenue / Est. (USD)
80,92 млн / 80,50 млн
+0,52%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қар.
2026 ж. ақп.
2026 ж. мам.
2026 ж. там.
Revenue
79,43 млн
78,42 млн
86,61 млн
80,92 млн
Cost of goods sold
34,65 млн
36,94 млн
39,83 млн
34,08 млн
Cost of revenue
34,65 млн
36,94 млн
39,83 млн
34,08 млн
Research and development expenses
7,63 млн
6,93 млн
8,03 млн
7,82 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
37,00 млн
38,31 млн
41,53 млн
42,61 млн
Operating expense
47,27 млн
47,91 млн
52,42 млн
53,16 млн
Total operating expenses
81,92 млн
84,85 млн
92,26 млн
87,24 млн
Operating income
-2,49 млн
-6,43 млн
-5,65 млн
-6,32 млн
Other non operating income
-128,00 м.
4,97 млн
-735,00 м.
94,00 мың
EBT including unusual items
-6,36 млн
-8,07 млн
-11,04 млн
-7,30 млн
EBT excluding unusual items
-2,72 млн
-1,55 млн
-6,49 млн
-6,32 млн
Income tax expense
-5,00 мың
12,00 мың
370,00 м.
-199,00 м.
Effective tax rate
0,08%
-0,15%
-3,35%
2,73%
Other operating expenses
-
-
138,00 м.
-
Net income
-6,35 млн
-8,08 млн
-11,40 млн
-7,10 млн
Net profit margin
-7,99%
-10,31%
-13,17%
-8,77%
Earnings per share
-
0,02
-0,07
-0,04
Interest and investment income
-
12,00 мың
1,00 мың
-
Interest expense
-102,00 м.
-100,00 м.
-106,00 м.
-88,00 мың
Net interest expenses
-102,00 м.
-88,00 мың
-105,00 м.
-88,00 мың
Depreciation and amortization charges
-
-
-
-
EBITDA
3,26 млн
-838,00 м.
-353,00 м.
-823,00 м.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google қолданбалары